Department of Urology, Istanbul Bilim University, Istanbul, Turkey.
Department of Urology, Istanbul Florence Nightingale Hospital, Istanbul, Turkey.
J Endourol. 2019 Sep;33(9):761-766. doi: 10.1089/end.2018.0853. Epub 2019 Jul 17.
Postoperative lymphatic drainage and lymphocele formation is a common seen complication after extended pelvic lymph node dissection (ePLND) in robot-assisted radical prostatectomy (RARP) operation. The aim of this study was to evaluate autologous fibrin glue as an additional treatment option to reduce the volume of lymphatic drainage and prevent lymphocele development. A total of 75 patients undergoing transperitoneal RARP with ePLND between January and July 2018 were enrolled in this study. Thirty-five patients who received autologous fibrin glue enrolled to study group, another 40 patients who did not receive to control group. Autologous fibrin glue was applied over the PLND areas. Age, body mass index (BMI), pathologic stages, and number of removed lymph nodes (LNs) were compared. The main endpoint was to compare postoperative lymphatic drainage volume and lymphocele formation rate between groups. There was not statistically significant difference between the groups with respect to age, BMI, Gleason score, T-stage, and number of removed LNs. Autologous fibrin glue resulted in 50% (110 mL 210 mL; = 0.037) and 75% reduction of postoperative drainage volume (70 mL 270 mL; = < 0.0001) in study group than control group at postoperative 2nd and 3rd days, respectively. The total drainage volume was also 50% reduced in study group (277 mL 577 mL; = 0.004). The incidence of asymptomatic lymphocele was 20% ( = 7) and 37.5% ( = 15) in study and control groups, respectively ( = 0.112). One patient in control group developed symptomatic lymphocele. There were no immediate or late adverse effects in study group. Autologous fibrin glue application reduced postoperative lymphatic drainage, and also lymphocele formation rate after extended PLND in RARP operation.
术后淋巴引流和淋巴囊肿形成是机器人辅助根治性前列腺切除术(RARP)中扩大盆腔淋巴结清扫术(ePLND)后常见的并发症。本研究旨在评估自体纤维蛋白胶作为一种额外的治疗选择,以减少淋巴引流量并预防淋巴囊肿形成。
本研究共纳入 2018 年 1 月至 7 月期间接受经腹腔 RARP 联合 ePLND 的 75 例患者。其中 35 例患者接受自体纤维蛋白胶治疗,纳入研究组,另 40 例未接受治疗的患者纳入对照组。自体纤维蛋白胶应用于 PLND 区域。比较年龄、体重指数(BMI)、病理分期和切除淋巴结(LNs)数量。主要终点是比较两组术后淋巴引流量和淋巴囊肿形成率。
两组患者的年龄、BMI、Gleason 评分、T 分期和切除的 LNs 数量无统计学差异。与对照组相比,研究组术后第 2 天和第 3 天的术后引流量分别减少了 50%(110 毫升,210 毫升; = 0.037)和 75%(70 毫升,270 毫升; < 0.0001),术后第 2 天和第 3 天的引流总量也分别减少了 50%(277 毫升,577 毫升; = 0.004)。研究组无症状淋巴囊肿的发生率为 20%( = 7),对照组为 37.5%( = 15)( = 0.112)。对照组有 1 例发生症状性淋巴囊肿。研究组无即刻或迟发性不良反应。
自体纤维蛋白胶的应用可减少 RARP 中扩大 PLND 术后的淋巴引流,并降低淋巴囊肿的形成率。